Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Pengfu Fund is a specialized private equity investment vehicle focused on the biopharmaceutical and healthcare sectors in Shenzhen, China. Established as part of the city's strategic initiative to develop its '20+8' industrial clusters, the fund primarily targets innovations in drug discovery, high-end medical devices, and advanced healthcare services. It is specifically designed to bolster the biomedical industry ecosystem in the Pingshan District by providing growth capital and strategic resources to early and growth-stage companies. The fund is managed by Shenzhen Pengfu Investment Management and involves significant participation from government-guided investment platforms and industrial partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Pengfu Fund.